MedPath
TGA Approval

OPREXA olanzapine 2.5 mg tablet blister pack (335113)

335113

OPREXA olanzapine 2.5 mg tablet blister pack

Arrotex Pharmaceuticals Pty Ltd

July 1, 2020

Medicine

Medicine

Active

Registered

Active Ingredients

olanzapine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

OPREXA olanzapine 2.5 mg tablet blister pack (335113) - TGA 批准文号 | MedPath